Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunopathology of lung transplantation: from infection to rejection and vice versa.
Righi I, Barone I, Rosso L, Morlacchi LC, Rossetti V, Caffarena G, Limanaqi F, Palleschi A, Clerici M, Trabattoni D. Righi I, et al. Among authors: trabattoni d. Front Immunol. 2024 Sep 2;15:1433469. doi: 10.3389/fimmu.2024.1433469. eCollection 2024. Front Immunol. 2024. PMID: 39286256 Free PMC article. Review.
Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study.
Cazzullo CL, Sacchetti E, Galluzzo A, Panariello A, Adorni A, Pegoraro M, Bosis S, Colombo F, Trabattoni D, Zagliani A, Clerici M. Cazzullo CL, et al. Among authors: trabattoni d. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan;26(1):33-9. doi: 10.1016/s0278-5846(01)00221-4. Prog Neuropsychopharmacol Biol Psychiatry. 2002. PMID: 11853116 Clinical Trial.
Immune profiles of patients with chronic idiopathic urticaria.
Piconi S, Trabattoni D, Iemoli E, Fusi ML, Villa ML, Milazzo F, Clerici M. Piconi S, et al. Among authors: trabattoni d. Int Arch Allergy Immunol. 2002 May;128(1):59-66. doi: 10.1159/000058004. Int Arch Allergy Immunol. 2002. PMID: 12037402
Modulation of human immunodeficiency virus (HIV)-specific immune response by using efavirenz, nelfinavir, and stavudine in a rescue therapy regimen for HIV-infected, drug-experienced patients.
Trabattoni D, Lo Caputo S, Biasin M, Seminari E, Di Pietro M, Ravasi G, Mazzotta F, Maserati R, Clerici M. Trabattoni D, et al. Clin Diagn Lab Immunol. 2002 Sep;9(5):1114-8. doi: 10.1128/cdli.9.5.1114-1118.2002. Clin Diagn Lab Immunol. 2002. PMID: 12204968 Free PMC article. Clinical Trial.
415 results